March 25, 2019 / 1:11 PM / 4 months ago

REFILE-BRIEF-Shanghai Fosun Pharmaceutical's 2018 Net Profit Down 13.3 Percent Y/Y

(Refiles with additional bullet point, link)

March 25 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd:

* SAYS 2018 NET PROFIT DOWN 13.3 PERCENT Y/Y

* SAYS IT AND AFFILIATE AGREE TO BOOST BIOTECH FIRM'S CAPITAL BY A COMBINED 500 MILLION YUAN TO 790 MLN YUAN Source text in Chinese: bit.ly/2WlENlJ; bit.ly/2U6Sac5 Further company coverage: (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below